— Know what they know.
Not Investment Advice

RXRX NASDAQ

Recursion Pharmaceuticals, Inc.
1W: +10.2% 1M: +21.9% 3M: +4.0% YTD: -1.9% 1Y: -19.2% 3Y: -47.0% 5Y: -83.2%
$4.12
+0.05 (+1.23%)
 
Weekly Expected Move ±12.2%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 65 · $2.2B mcap · 409M float · 5.00% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$55M
Revenue
-14.9% YoY
$-519M
Net Income
+20.0% YoY
$-354M
Free Cash Flow
+10.1% YoY
-49.8%
Gross Margin
-1759.7%
Op. Margin
-1708.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-56.6%
ROA-41.3%
ROIC-99.7%

Valuation

P/E-4.0
P/B2.4
EV/EBITDA-3.3

Leverage

Debt/Equity0.07
Current Ratio5.03
Interest Cov.-350.4x

Quality Scores

Piotroski F4/9
Altman Z0.36
Beneish M-3.78

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms